BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210203T170000
DTEND;TZID=America/Vancouver:20210203T200000
DTSTAMP:20260411T042504
CREATED:20210125T194532Z
LAST-MODIFIED:20210125T194532Z
UID:11243-1612371600-1612382400@scienceinseattle.com
SUMMARY:Chiari Malformation Webinar
DESCRIPTION:Live webinar with physicians about Chiari Malformation
URL:https://scienceinseattle.com/event/chiari-malformation-webinar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210203T170000
DTEND;TZID=America/Vancouver:20210203T200000
DTSTAMP:20260411T042504
CREATED:20210125T194532Z
LAST-MODIFIED:20210125T194532Z
UID:25661-1612371600-1612382400@scienceinseattle.com
SUMMARY:Chiari Malformation Webinar
DESCRIPTION:Live webinar with physicians about Chiari Malformation
URL:https://scienceinseattle.com/event/chiari-malformation-webinar-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210203T170000
DTEND;TZID=America/Vancouver:20210203T200000
DTSTAMP:20260411T042504
CREATED:20210125T194532Z
LAST-MODIFIED:20210125T194532Z
UID:26626-1612371600-1612382400@scienceinseattle.com
SUMMARY:Chiari Malformation Webinar
DESCRIPTION:Live webinar with physicians about Chiari Malformation
URL:https://scienceinseattle.com/event/chiari-malformation-webinar-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210204T170000
DTEND;TZID=America/Vancouver:20210204T180000
DTSTAMP:20260411T042504
CREATED:20210201T181407Z
LAST-MODIFIED:20210201T181407Z
UID:11326-1612458000-1612461600@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, February 04\, 2021\n\n\nStart Time:\n5 p.m. PST\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nJohn Gore\, MD\, MS\, FACS\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210204T170000
DTEND;TZID=America/Vancouver:20210204T180000
DTSTAMP:20260411T042504
CREATED:20210201T181407Z
LAST-MODIFIED:20210201T181407Z
UID:25664-1612458000-1612461600@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, February 04\, 2021\n\n\nStart Time:\n5 p.m. PST\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nJohn Gore\, MD\, MS\, FACS\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210204T170000
DTEND;TZID=America/Vancouver:20210204T180000
DTSTAMP:20260411T042504
CREATED:20210201T181407Z
LAST-MODIFIED:20210201T181407Z
UID:26629-1612458000-1612461600@scienceinseattle.com
SUMMARY:GU Oncology Seminar Series
DESCRIPTION:The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch\, UW\, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE\, Program in Prostate Cancer Research (PPCR)\, and Bladder Cancer Group (BCG). \nLivestream:  https://us02web.zoom.us/j/85023704247\nFeedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback \nView past seminar recordings \n\n\n\n\n\nDate:\nThursday\, February 04\, 2021\n\n\nStart Time:\n5 p.m. PST\n\n\nHost or Sponsor:\nPacific Northwest Prostate Cancer SPORE\n\n\nLocation:\nVirtual\n\n\nSpeaker or Presenter:\nJohn Gore\, MD\, MS\, FACS\n\n\nContact Information:\nPPCR_SPOREadmin@fredhutch.org
URL:https://scienceinseattle.com/event/gu-oncology-seminar-series-2-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260411T042504
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:11441-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260411T042504
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:25669-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260411T042504
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:26634-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260411T042504
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:11431-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260411T042504
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:25666-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260411T042504
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:26631-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210217T120000
DTEND;TZID=America/Vancouver:20210217T130000
DTSTAMP:20260411T042504
CREATED:20210208T181806Z
LAST-MODIFIED:20210208T181806Z
UID:11438-1613563200-1613566800@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nLung cancer is one of the most common cancers worldwide and the leading cause of cancer deaths both globally and in the United States. The National Lung Cancer Screening Trial showed annual screening by low-dose computed tomography (LDCT) reduced mortality and in 2013 the US Preventative Services Task Force recommended screening by LDCT for high-risk smokers. A predictive model for 6-year risk of lung cancer was developed using results of the Prostate\, Lung\, Colon\, and Ovarian Cancer Screening Trial (PLCOm2012) and put forth as selection criteria for referral to screening. The Hanash Lab at MD Anderson has established and validated a panel of four circulating protein biomarkers (4MP) for lung cancer risk assessment. In this talk\, I will describe joint work with Ziding Feng and the Hanash lab leading to a definitive validation of the 4MP using preclinical specimens from the PLCO biorepository\, highlight validation of selection criteria based on combining the 4MP with PLCOm2012\, and discuss next steps for investigating the clinical utility of a biomarker-based strategy for referral to LDCT screening.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210217T120000
DTEND;TZID=America/Vancouver:20210217T130000
DTSTAMP:20260411T042504
CREATED:20210208T181806Z
LAST-MODIFIED:20210208T181806Z
UID:25668-1613563200-1613566800@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nLung cancer is one of the most common cancers worldwide and the leading cause of cancer deaths both globally and in the United States. The National Lung Cancer Screening Trial showed annual screening by low-dose computed tomography (LDCT) reduced mortality and in 2013 the US Preventative Services Task Force recommended screening by LDCT for high-risk smokers. A predictive model for 6-year risk of lung cancer was developed using results of the Prostate\, Lung\, Colon\, and Ovarian Cancer Screening Trial (PLCOm2012) and put forth as selection criteria for referral to screening. The Hanash Lab at MD Anderson has established and validated a panel of four circulating protein biomarkers (4MP) for lung cancer risk assessment. In this talk\, I will describe joint work with Ziding Feng and the Hanash lab leading to a definitive validation of the 4MP using preclinical specimens from the PLCO biorepository\, highlight validation of selection criteria based on combining the 4MP with PLCOm2012\, and discuss next steps for investigating the clinical utility of a biomarker-based strategy for referral to LDCT screening.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210217T120000
DTEND;TZID=America/Vancouver:20210217T130000
DTSTAMP:20260411T042504
CREATED:20210208T181806Z
LAST-MODIFIED:20210208T181806Z
UID:26633-1613563200-1613566800@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nLung cancer is one of the most common cancers worldwide and the leading cause of cancer deaths both globally and in the United States. The National Lung Cancer Screening Trial showed annual screening by low-dose computed tomography (LDCT) reduced mortality and in 2013 the US Preventative Services Task Force recommended screening by LDCT for high-risk smokers. A predictive model for 6-year risk of lung cancer was developed using results of the Prostate\, Lung\, Colon\, and Ovarian Cancer Screening Trial (PLCOm2012) and put forth as selection criteria for referral to screening. The Hanash Lab at MD Anderson has established and validated a panel of four circulating protein biomarkers (4MP) for lung cancer risk assessment. In this talk\, I will describe joint work with Ziding Feng and the Hanash lab leading to a definitive validation of the 4MP using preclinical specimens from the PLCO biorepository\, highlight validation of selection criteria based on combining the 4MP with PLCOm2012\, and discuss next steps for investigating the clinical utility of a biomarker-based strategy for referral to LDCT screening.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-2-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210222T080000
DTEND;TZID=America/Vancouver:20210222T090000
DTSTAMP:20260411T042504
CREATED:20210208T181649Z
LAST-MODIFIED:20210208T181649Z
UID:11434-1613980800-1613984400@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series
DESCRIPTION:The Global Oncology (GO) Lecture Series Webinar features presentations with unique perspectives. The goal of the webinar series is to bring together those working in the global cancer field to share research or program updates and establish closer working collaborations. Each webinar includes an hour-long presentation and discussion during which speakers showcase their work and findings. The series allows Fred Hutch faculty\, employees\, Consortium members\, students\, and global cancer or global health community members to be a part of this important conversation. \nHenry Ddungu\, MBChB\, MMed\, Hematology Consultant\, Uganda Cancer Institute\nPRESENTING: Optimal Use of Platelet Transfusion in Cancer (OPTIC) in sub-Saharan Africa \nDr. Ddungu began his Ph.D. studies in Seattle with coursework at the University of Washington and clinical oncology rotations at Seattle Cancer Care Alliance and Harborview Medical Center. Since returning to Kampala in 2012\, he has continued his doctoral research at Makerere University\, studying the optimal use of platelet transfusion for oncology patients at the UCI. He is currently a hematologist and director of laboratory operations at the UCI.
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210222T080000
DTEND;TZID=America/Vancouver:20210222T090000
DTSTAMP:20260411T042504
CREATED:20210208T181649Z
LAST-MODIFIED:20210208T181649Z
UID:25667-1613980800-1613984400@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series
DESCRIPTION:The Global Oncology (GO) Lecture Series Webinar features presentations with unique perspectives. The goal of the webinar series is to bring together those working in the global cancer field to share research or program updates and establish closer working collaborations. Each webinar includes an hour-long presentation and discussion during which speakers showcase their work and findings. The series allows Fred Hutch faculty\, employees\, Consortium members\, students\, and global cancer or global health community members to be a part of this important conversation. \nHenry Ddungu\, MBChB\, MMed\, Hematology Consultant\, Uganda Cancer Institute\nPRESENTING: Optimal Use of Platelet Transfusion in Cancer (OPTIC) in sub-Saharan Africa \nDr. Ddungu began his Ph.D. studies in Seattle with coursework at the University of Washington and clinical oncology rotations at Seattle Cancer Care Alliance and Harborview Medical Center. Since returning to Kampala in 2012\, he has continued his doctoral research at Makerere University\, studying the optimal use of platelet transfusion for oncology patients at the UCI. He is currently a hematologist and director of laboratory operations at the UCI.
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210222T080000
DTEND;TZID=America/Vancouver:20210222T090000
DTSTAMP:20260411T042504
CREATED:20210208T181649Z
LAST-MODIFIED:20210208T181649Z
UID:26632-1613980800-1613984400@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series
DESCRIPTION:The Global Oncology (GO) Lecture Series Webinar features presentations with unique perspectives. The goal of the webinar series is to bring together those working in the global cancer field to share research or program updates and establish closer working collaborations. Each webinar includes an hour-long presentation and discussion during which speakers showcase their work and findings. The series allows Fred Hutch faculty\, employees\, Consortium members\, students\, and global cancer or global health community members to be a part of this important conversation. \nHenry Ddungu\, MBChB\, MMed\, Hematology Consultant\, Uganda Cancer Institute\nPRESENTING: Optimal Use of Platelet Transfusion in Cancer (OPTIC) in sub-Saharan Africa \nDr. Ddungu began his Ph.D. studies in Seattle with coursework at the University of Washington and clinical oncology rotations at Seattle Cancer Care Alliance and Harborview Medical Center. Since returning to Kampala in 2012\, he has continued his doctoral research at Makerere University\, studying the optimal use of platelet transfusion for oncology patients at the UCI. He is currently a hematologist and director of laboratory operations at the UCI.
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-2-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260411T042504
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:11329-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260411T042504
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:25665-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260411T042504
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:26630-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210224T100000
DTEND;TZID=America/Vancouver:20210224T110000
DTSTAMP:20260411T042504
CREATED:20210125T194407Z
LAST-MODIFIED:20210125T194407Z
UID:11240-1614160800-1614164400@scienceinseattle.com
SUMMARY:Open for (Neuro)Science Tutorials: New from the Allen Cell Types Database
DESCRIPTION:Open for (neuro)science tutorials: New from the Allen Cell Types Database\n\n\n\n\n\nDate:\nWednesday\, February 24\, 2021\nTime:\n10:00 AM – 11:00 AM\nLocation:\n\nVirtual\n\n\nJoin us at this tutorial to learn about new work from the Allen Cell Types Database\, including patch-seq and synaptic physiology data. Learn how and why to use these open resources to support and accelerate your research.
URL:https://scienceinseattle.com/event/open-for-neuroscience-tutorials-new-from-the-allen-cell-types-database/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210224T100000
DTEND;TZID=America/Vancouver:20210224T110000
DTSTAMP:20260411T042504
CREATED:20210125T194407Z
LAST-MODIFIED:20210125T194407Z
UID:25660-1614160800-1614164400@scienceinseattle.com
SUMMARY:Open for (Neuro)Science Tutorials: New from the Allen Cell Types Database
DESCRIPTION:Open for (neuro)science tutorials: New from the Allen Cell Types Database\n\n\n\n\n\nDate:\nWednesday\, February 24\, 2021\nTime:\n10:00 AM – 11:00 AM\nLocation:\n\nVirtual\n\n\nJoin us at this tutorial to learn about new work from the Allen Cell Types Database\, including patch-seq and synaptic physiology data. Learn how and why to use these open resources to support and accelerate your research.
URL:https://scienceinseattle.com/event/open-for-neuroscience-tutorials-new-from-the-allen-cell-types-database-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210224T100000
DTEND;TZID=America/Vancouver:20210224T110000
DTSTAMP:20260411T042504
CREATED:20210125T194407Z
LAST-MODIFIED:20210125T194407Z
UID:26625-1614160800-1614164400@scienceinseattle.com
SUMMARY:Open for (Neuro)Science Tutorials: New from the Allen Cell Types Database
DESCRIPTION:Open for (neuro)science tutorials: New from the Allen Cell Types Database\n\n\n\n\n\nDate:\nWednesday\, February 24\, 2021\nTime:\n10:00 AM – 11:00 AM\nLocation:\n\nVirtual\n\n\nJoin us at this tutorial to learn about new work from the Allen Cell Types Database\, including patch-seq and synaptic physiology data. Learn how and why to use these open resources to support and accelerate your research.
URL:https://scienceinseattle.com/event/open-for-neuroscience-tutorials-new-from-the-allen-cell-types-database-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210226T100000
DTEND;TZID=America/Vancouver:20210226T113000
DTSTAMP:20260411T042504
CREATED:20210218T192048Z
LAST-MODIFIED:20210218T192048Z
UID:11532-1614333600-1614339000@scienceinseattle.com
SUMMARY:Creating a Successful Academic Spin-Out
DESCRIPTION:Live\, 90-minute event featuring 3 distinguished academics / entrepreneurs discussing their Academic Spin-Out successes\, adventures and insights. \nBill Walker describes launching four companies from within academia and from coaching dozens of academic startups. He will share the general principles he’s identified and some of the ways that academic ventures go off the rails. \nLori Arakaki shares insights and lessons from her just closed $4.6 Million in funding to develop the first cell O2 monitor for reducing organ failure as she describes Opticyte’s journey so far. \nDr. Magdy Younes draws upon his experience as a Canadian physician and researcher specializing in respirology and sleep medicine to share how an academic physician ended up being an inventor/entrepreneur? Spoiler alert: “It is not what you think”. \nEach presenter will include plenty of examples and actionable advice. \n“Fantastic presenters and very informative. Thank you.” -Attendee Feedback from previous Virtual Medical Device Playbook events. \n#MDPLAYBOOK \nTOPICS:\nBehaviors and decisions that seem to be almost universally fatal for Academic Spin-Outs \nHow do I know if I have a good idea? • Should I leave my day job? • How can I find a “good” CEO to run my venture? • Where do I go to raise money? \nRaising capital\, grant strategies\, relationship with university \nUnique struggles that co-founders who are academics can face and need to overcome
URL:https://scienceinseattle.com/event/creating-a-successful-academic-spin-out/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/Creating-Successful-Academic-SpinOuts.jpg
ORGANIZER;CN="StarFish Medical":MAILTO:mcamplin@starfishmedical.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210226T100000
DTEND;TZID=America/Vancouver:20210226T113000
DTSTAMP:20260411T042504
CREATED:20210218T192048Z
LAST-MODIFIED:20210218T192048Z
UID:25670-1614333600-1614339000@scienceinseattle.com
SUMMARY:Creating a Successful Academic Spin-Out
DESCRIPTION:Live\, 90-minute event featuring 3 distinguished academics / entrepreneurs discussing their Academic Spin-Out successes\, adventures and insights. \nBill Walker describes launching four companies from within academia and from coaching dozens of academic startups. He will share the general principles he’s identified and some of the ways that academic ventures go off the rails. \nLori Arakaki shares insights and lessons from her just closed $4.6 Million in funding to develop the first cell O2 monitor for reducing organ failure as she describes Opticyte’s journey so far. \nDr. Magdy Younes draws upon his experience as a Canadian physician and researcher specializing in respirology and sleep medicine to share how an academic physician ended up being an inventor/entrepreneur? Spoiler alert: “It is not what you think”. \nEach presenter will include plenty of examples and actionable advice. \n“Fantastic presenters and very informative. Thank you.” -Attendee Feedback from previous Virtual Medical Device Playbook events. \n#MDPLAYBOOK \nTOPICS:\nBehaviors and decisions that seem to be almost universally fatal for Academic Spin-Outs \nHow do I know if I have a good idea? • Should I leave my day job? • How can I find a “good” CEO to run my venture? • Where do I go to raise money? \nRaising capital\, grant strategies\, relationship with university \nUnique struggles that co-founders who are academics can face and need to overcome
URL:https://scienceinseattle.com/event/creating-a-successful-academic-spin-out-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/Creating-Successful-Academic-SpinOuts.jpg
ORGANIZER;CN="StarFish Medical":MAILTO:mcamplin@starfishmedical.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210226T100000
DTEND;TZID=America/Vancouver:20210226T113000
DTSTAMP:20260411T042504
CREATED:20210218T192048Z
LAST-MODIFIED:20210218T192048Z
UID:26635-1614333600-1614339000@scienceinseattle.com
SUMMARY:Creating a Successful Academic Spin-Out
DESCRIPTION:Live\, 90-minute event featuring 3 distinguished academics / entrepreneurs discussing their Academic Spin-Out successes\, adventures and insights. \nBill Walker describes launching four companies from within academia and from coaching dozens of academic startups. He will share the general principles he’s identified and some of the ways that academic ventures go off the rails. \nLori Arakaki shares insights and lessons from her just closed $4.6 Million in funding to develop the first cell O2 monitor for reducing organ failure as she describes Opticyte’s journey so far. \nDr. Magdy Younes draws upon his experience as a Canadian physician and researcher specializing in respirology and sleep medicine to share how an academic physician ended up being an inventor/entrepreneur? Spoiler alert: “It is not what you think”. \nEach presenter will include plenty of examples and actionable advice. \n“Fantastic presenters and very informative. Thank you.” -Attendee Feedback from previous Virtual Medical Device Playbook events. \n#MDPLAYBOOK \nTOPICS:\nBehaviors and decisions that seem to be almost universally fatal for Academic Spin-Outs \nHow do I know if I have a good idea? • Should I leave my day job? • How can I find a “good” CEO to run my venture? • Where do I go to raise money? \nRaising capital\, grant strategies\, relationship with university \nUnique struggles that co-founders who are academics can face and need to overcome
URL:https://scienceinseattle.com/event/creating-a-successful-academic-spin-out-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/Creating-Successful-Academic-SpinOuts.jpg
ORGANIZER;CN="StarFish Medical":MAILTO:mcamplin@starfishmedical.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210302T170000
DTEND;TZID=America/Vancouver:20210302T180000
DTSTAMP:20260411T042504
CREATED:20210226T005145Z
LAST-MODIFIED:20210226T010229Z
UID:11653-1614704400-1614708000@scienceinseattle.com
SUMMARY:Webinar Series: The Microbiome and Different Diets
DESCRIPTION:WHEN\nTuesday\, Mar 2\, 2021\, 5 – 6 p.m.\n\n\n\nMonthly on the 1st Tuesday of the month starting March 2\, 2021 through July 6\, 2021\n\n\n\n\n\n\nDESCRIPTION\n\nJoin William DePaolo\, PhD\, immunologist and intestinal microbiome specialist\, Division of Gastroenterology\, UW Medicine\, for a five part seminar series on the microbiome.  All seminars will be via Zoom at 5:00 PM (PT) on the first Tuesday of the month.  This is a free series and you are welcome to attend all or just one but\, you must register to receive the Zoom link and passcode. \n*Please note that a new Zoom passcode will be sent out prior to each talk.* \nMarch 2 – Different diets\nApril 6 – Lifestyle\nMay 4 – COVID19\nJune 1 – Antibiotics\nJuly 6 – Over-the-counter-drugs & probiotics \nRegister for one or all talks\, here. \nQuestions? Email Amy Parker\, ‘Parker\,’ at aparker@medicine.washington.edu \nPDF flyer \n\n\n\nEVENT TYPES\nLectures/Seminars\n\n\nEVENT SPONSORS
URL:https://scienceinseattle.com/event/webinar-series-the-microbiome-and-different-diets/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/The-Microbiome-and...jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210302T170000
DTEND;TZID=America/Vancouver:20210302T180000
DTSTAMP:20260411T042504
CREATED:20210226T005145Z
LAST-MODIFIED:20210226T005145Z
UID:25673-1614704400-1614708000@scienceinseattle.com
SUMMARY:Webinar Series: The Microbiome and Different Diets
DESCRIPTION:WHEN\nTuesday\, Mar 2\, 2021\, 5 – 6 p.m.\n\n\n\nMonthly on the 1st Tuesday of the month starting March 2\, 2021 through July 6\, 2021\n\n\n\n\n\n\nDESCRIPTION\n\nJoin William DePaolo\, PhD\, immunologist and intestinal microbiome specialist\, Division of Gastroenterology\, UW Medicine\, for a five part seminar series on the microbiome.  All seminars will be via Zoom at 5:00 PM (PT) on the first Tuesday of the month.  This is a free series and you are welcome to attend all or just one but\, you must register to receive the Zoom link and passcode. \n*Please note that a new Zoom passcode will be sent out prior to each talk.* \nMarch 2 – Different diets\nApril 6 – Lifestyle\nMay 4 – COVID19\nJune 1 – Antibiotics\nJuly 6 – Over-the-counter-drugs & probiotics \nRegister for one or all talks\, here. \nQuestions? Email Amy Parker\, ‘Parker\,’ at aparker@medicine.washington.edu \nPDF flyer \n\n\n\nEVENT TYPES\nLectures/Seminars\n\n\nEVENT SPONSORS
URL:https://scienceinseattle.com/event/webinar-series-the-microbiome-and-different-diets-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/The-Microbiome-and...jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210302T170000
DTEND;TZID=America/Vancouver:20210302T180000
DTSTAMP:20260411T042504
CREATED:20210226T005145Z
LAST-MODIFIED:20210226T005145Z
UID:26638-1614704400-1614708000@scienceinseattle.com
SUMMARY:Webinar Series: The Microbiome and Different Diets
DESCRIPTION:WHEN\nTuesday\, Mar 2\, 2021\, 5 – 6 p.m.\n\n\n\nMonthly on the 1st Tuesday of the month starting March 2\, 2021 through July 6\, 2021\n\n\n\n\n\n\nDESCRIPTION\n\nJoin William DePaolo\, PhD\, immunologist and intestinal microbiome specialist\, Division of Gastroenterology\, UW Medicine\, for a five part seminar series on the microbiome.  All seminars will be via Zoom at 5:00 PM (PT) on the first Tuesday of the month.  This is a free series and you are welcome to attend all or just one but\, you must register to receive the Zoom link and passcode. \n*Please note that a new Zoom passcode will be sent out prior to each talk.* \nMarch 2 – Different diets\nApril 6 – Lifestyle\nMay 4 – COVID19\nJune 1 – Antibiotics\nJuly 6 – Over-the-counter-drugs & probiotics \nRegister for one or all talks\, here. \nQuestions? Email Amy Parker\, ‘Parker\,’ at aparker@medicine.washington.edu \nPDF flyer \n\n\n\nEVENT TYPES\nLectures/Seminars\n\n\nEVENT SPONSORS
URL:https://scienceinseattle.com/event/webinar-series-the-microbiome-and-different-diets-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2021/02/The-Microbiome-and...jpeg
END:VEVENT
END:VCALENDAR